4.3 Article

Ovulation induction and risk of endometrial cancer: a pilot study

出版社

ELSEVIER
DOI: 10.1016/S0301-2115(01)00344-X

关键词

ovulation induction; clomiphene; infertility; endometrial cancer; case-control study

向作者/读者索取更多资源

Objective: To determine whether women with endometrial carcinoma are more likely to have been exposed to fertility drugs, in particular clomiphene, than healthy population controls. Study design: A nationwide case-control, pilot study. About 128 living women 35-64 years old, with a histologicaly confirmed diagnosis of endometrial carcinoma that was first diagnosed and reported to The Israel Cancer Registry between I January 1989 and 31 December 1992 were enrolled. The controls were 255 women from the same dialing areas selected by random digit dialing. A variety of demographic and clinical parameters were compared between cases and controls. A multivariate logistic model, controlling for age, was used to assess the independent effects of factors found to be significantly associated with endometrial cancer on univariate analysis. Results: About 7 women with endometrial carcinoma (5.5%) and 10 healthy controls (3.9%) reported that they had used any fertility drug (crude odds ratio (OR) 1.4; 95% confidence interval (CI) 0.47-4.2). Use of fertility drugs did not meet the criteria for entry into the logistic model. The following parameters were found to be independently associated with endometrial cancer controlling for age, European-American background OR 2.2, (95% CI 1.3-3.7, P = 0.004); nulliparity OR = 2.7 (95% CI 1.1-6.5, P = 0.03); history of infertility OR = 1.8 (95% Cl 1.0-3.3, P = 0.05); BMI greater than or equal to 27 OR = 2.3 (95% CI 1.4-3.9, P = 0.001). The use of oral contraceptives and IUD were found to be protective, OR 0.29 and 0.37, respectively, (95% CI 0.14-0.61, P = 0.001 and 0.19-0.70, P = 0.003, respectively). Conclusions: We found no evidence that the use of ovulation induction agents, including clomiphene citrate, are associated with a higher risk of endometrial carcinoma. The association between infertility drugs and endometrial carcinoma should be examined in other, larger studies. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据